Secondary prevention of acute venous thrombosis. Modern trends

Амбулаторная хирургия

V. N. Lobanov¹  B. V. Boldin²  V. Y. Bogachev²  O. V. Dzhenina² 

[1] First Phlebologic Center;Pirogov Russian Scientific and Research Medical University;

关键词: венозные тромбоэмболические осложнения;    факторы риска;    антикоагулянтная терапия;    сулодексид;    venous thrombolic complications;    risk factors;    anticoagulant therapy;    sulodexide;   

DOI  :  

来源: DOAJ

【 摘 要 】

Venous thromboembolic complications (VTC) including deep veins thrombosis and pulmonary artery thromboembolia are sufficiently frequent but preventable states. In industrially developed countries 1-2 cases of VTC per 1 thousand persons per year are registered. In USA 900 thousand patients suffer from VTC annually. But these figures are most likely conservative as due to diffuseness of a clinical pattern and insufficient sensitivity of screening tests the frequency of verified VTC doesn't exceed 60-70% [1, 2].

【 授权许可】

Unknown